AchE Inhibitor and Insulin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions

Diabetes Mellitus

Interventions

DRUG

Pyridostigmine

single oral dose of 60 mg pyridostigmine tablet

Trial Locations (1)

Diabetes Research Institute, Miami

All Listed Sponsors

collaborator

American Diabetes Association

OTHER

lead

University of Miami

OTHER

NCT03063515 - AchE Inhibitor and Insulin | Biotech Hunter | Biotech Hunter